Advertisement
UK markets closed
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • FTSE 250

    19,719.37
    -80.35 (-0.41%)
     
  • AIM

    754.69
    -0.18 (-0.02%)
     
  • GBP/EUR

    1.1632
    +0.0004 (+0.04%)
     
  • GBP/USD

    1.2435
    -0.0017 (-0.14%)
     
  • Bitcoin GBP

    52,153.46
    -1,327.09 (-2.48%)
     
  • CMC Crypto 200

    1,398.73
    -25.37 (-1.78%)
     
  • S&P 500

    5,053.31
    -17.24 (-0.34%)
     
  • DOW

    38,361.70
    -141.99 (-0.37%)
     
  • CRUDE OIL

    82.83
    -0.53 (-0.64%)
     
  • GOLD FUTURES

    2,338.60
    -3.50 (-0.15%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • CAC 40

    8,091.86
    -13.92 (-0.17%)
     

Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™

Immunocore Holdings Limited
Immunocore Holdings Limited